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Abstract
This study is based on a plan of collecting different matrices (hair, eye, muscle, liver and kidney) in order to define a
strategy for the control of the illegal use of clenbuterol in bovine production. Of all matrices utilised, hair is
recommended for the analytical control of clenbuterol in living animals, due to its being permanently available and easy
to collect. The eye, or rather the retina, is the matrix which gives the most trustworthy result, after the animal slaughter,
and the one that best helps in the determination of the illegal use of clenbuterol in a perspective of gradual food safety
improvement.
# 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
The number of medicines used to promote
animal growth has been increasing exponentially,
mainly due to the modern practices of intensive
animal husbandry.
Although clenbuterol (4-amino-3,5-dichloro-a-
[(tert -butylamino)methyl]benzyl alcohol hydro-
chloride) is authorised in the veterinarian thera-
peutics of bovines, equines and pet animals as a
bronchodilatant or as a tocolitic agent in cows [1];
it has also been illegally used [2,3] to promote
animal growth, causing a considerable increase in
muscular mass and, at the same time, a decrease in
fat accumulation [4,5]. However, in some cases, the
presence of non-negligible amounts of drug resi-
dues in meat is a real public health problem and
various food poisoning situations have been de-
scribed as being due to clenbuterol residues in liver
and meat [6/13].
In order to define a strategy for the control of
the illegal use of clenbuterol in bovine production,
a plan of collecting different matrices (hair, eye,
muscle, liver and kidney) was performed. Thus, the
purpose of this study was to define a possible ideal
moment of analysis for each one of the utilised
matrices, which must be applied to meet the
current quality standards of food safety.
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2. Experimental
2.1. Reagents and materials
Standards of clenbuterol and hexadeutered
clenbuterol (d6) were supplied by Interchim (Mon-
tluc¸on, France) and by RIVM (Bilthoven, the
Netherlands), respectively. Derivatiser reagent
was prepared by mixing the three reagents, N -
methyl-N -trimethylsilyl-trifluoracetamide
(MSTA; Macherey-Nagel, Du¨ren, Germany), di-
tioeritritol (DTE; Merck, Lisbon, Portugal) and
trimethyliodosilane (TMIS; Sigma, Madrid,
Spain) in the proportion 5 ml:20 mg:20 ml
(MSTA:DTE:TMIS). Purified water was obtained
with a Milli-Q Plus system by Millipore (Bedford,
MA, USA) and all other reagents utilised were
from Merck.
Homogenisation and clenbuterol residue extrac-
tion from liver, kidney and muscle samples were
performed with a Stomacher† (IUL Instruments,
Anatrom, Oporto, Portugal) and with an ultra-
sonic probe (Vibra Cell CV17, Sonics & Materials,
Danbury, CT). Extract purification was under-
taken by solid-phase extraction (SPE) on a va-
cuum manifold system with Chromabond C18 and
mixed-phase (C8/SCX) 500 mg columns, respec-
tively, from Macherey-Nagel and from Worldwide
Monitoring, USA, supplied by Reagente 5
(Oporto, Portugal). Centrifugation was done
with a minimal 3000/g force (Selecta Meditronic,
Barcelona, Spain), and the pH evaluations were
done with a WPA CD7400 potentiometer (Cam-
bridge, UK). Material for derivatisation and
automatic injection used for chromatography
was supplied by Chromacol (Dias de Sousa,
Lisbon, Portugal).
Clenbuterol determination was achieved by gas
chromatography/mass spectrometry (GC/MS)
with Hewlett-Packard (HP) equipment (Soquı´-
mica, Lisbon, Portugal), comprising an HP5890
Series II gas/liquid chromatograph, an HP6890
automatic injector, an HP5972 MSD detector, an
HP Vectra VL2 4/50 computer, an HP DeskJet 520
printer, and an HP-5MS column with a length of
30 m, 0.25 mm of internal diameter and 0.25 mm of
film thickness. The gases utilised, nitrogen N45
and helium N55, were supplied by Sogafer (Coim-
bra, Portugal).
2.2. Samples
Samples were collected in two slaughterhouses
of Leiria district (Portugal) from 13 calves,
younger than 12 months old, with various hair
colours. All these animals were suspected of having
been fattened through the use of clenbuterol. The
amounts of hair (9/15 g), eye (2), muscle (9/50 g),
liver (9/50 g) and kidney (1) collected from each
animal were transported, on the sampling day, in a
refrigerated box (49/2 8C) to the laboratory, where
they were kept in a deep freezer (/209/2 8C) until
the beginning of the analysis.
2.3. Sample preparation
2.3.1. Hair
Common scissors were used to cut hair samples
from each slaughtered animal. Hair was washed
with a solution of Tween 80 at 5% in water. The
sample was then rinsed in purified water as often
as necessary until the washing water was clear.
Hair sample was dried in an oven at 40 8C, and
subsequently cut into small pieces of 1/2 mm. An
amount of 1.09/0.1 g was placed in a centrifuge
tube to which 3 ml of NaOH 2 M and 100 ml of
internal standard, hexadeutered clenbuterol in a
methanolic solution of 1 mg/ml, were added.
Following homogenisation, the sample was di-
gested at 809/5 8C for 1 h, with agitation every 15
min [14,15]. After cooling to room temperature,
the pH of the digest was set to values of 6.09/0.5
with 2 M HCl. A centrifugal step was performed
for 5 min and the supernatant was filtered. The
sediment was resuspended with 5 ml of phosphate
buffer (pH 6.09/0.1; 0.1 M) and was again
centrifuged for 5 min. The second supernatant
was also filtered and mixed with the previous one.
2.3.2. Liver, muscle and kidney
An aliquot of 109/0.1 g of liver, muscle or
kidney, previously homogenised in a meat grinder,
was subjected to a Stomacher† extraction with
acetate buffer (pH 5.99/0.1; 0.2 M) and subse-
quently submitted to ultrasonification with a
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probe. An 100 ml of internal standard solution was
then added and the sample was set to pH 1.09/0.3
with concentrated perchloric acid and centrifuged.
Supernatant was removed and the pH was again
adjusted to 9.59/0.3 with ammonia at 32%.
Alkalised solution was saturated with sodium
chloride and submitted to a liquid/liquid extrac-
tion through a mixture of isopropanol:ethyl ace-
tate (40:60, v/v). Organic phase was recovered and
the extraction was repeated under the above-
mentioned conditions. The two portions of the
organic phase were joined together before being
evaporated almost until dry in a rotavapor [16/
18]. The residue was recovered with 10 ml of
phosphate buffer.
2.3.3. Eye
Collection of bovine eyes was made with dis-
posable surgical gloves and scalpels. The whole
eyeball and part of the optical nerve were removed.
Retina separation from the remaining components
of the eye was made from the whole, semi-frozen
eye, which was cut in half. Crystalline, and
vitreous and aqueous humours were eliminated.
Retina of both halves was separated from the
other eye components, cut and weighed. Retina
was cut into small fragments and placed in a
centrifuge tube, where 10 ml of acetate buffer (pH
5.99/0.1; 0.2 M) and 100 ml of internal standard
were added. After vortex homogenisation for 1
min, the sample was placed in an ultrasound bath
for 10 min, following by centrifugation. Super-
natant was filtered, and NaOH 2 M was added
until a final pH of 9.59/0.5 was attained [19]. After
this step, disposable material and eyeball rests,
retina included, were properly stored and inciner-
ated according to the Portuguese BSE program
eradication.
2.4. Solid-phase extraction
Extracts of hair, liver, muscle and kidney
samples were purified by SPE with mixed-phase
columns. Sorbent was activated with methanol,
water and phosphate buffer, following which the
respective extract was passed through the column.
Washing step was done with acetic acid and
methanol, and the sorbent was dried, after each
washing solvent, through centrifugation. Elution
of the analyte was done with ethyl acetate:ammo-
nia 32% [20,21].
Retina extracts were submitted to SPE with C18
columns. Sorbent activation was done with metha-
nol and water, after which the sample extract was
passed through. Columns were washed with water
and the excess solvent was eliminated by centrifu-
gation. Clenbuterol was eluted with methanol [21].
2.5. Derivatisation
Eluates were evaporated to dryness under a
nitrogen stream at 45 8C. The residue was dis-
solved in methanol and transferred to a derivatisa-
tion vial. Methanol was also evaporated to dryness
under the conditions mentioned above for the
eluates, and the resulting dry residue was re-
dissolved with 50 ml of derivatisation reagent.
After vial encapsulation, derivatisation was under-
taken for 20 min at 60 8C [12].
2.6. Chromatography
An aliquot of 2 ml was injected into the GC/MS
system in splitless mode, 1 min, using helium as
carrier gas. Injector and detector temperatures were
260 and 280 8C, respectively, and determination
was done in the electron impact mode with selective
ion monitoring: m /z 86 and 92, respectively, for
clenbuterol and hexadeutered clenbuterol, and m /z
300, 335 and 337 for both. The results were
obtained through the ratio between the ion peak
areas: m /z 86 for clenbuterol and m /z 92 for
hexadeutered clenbuterol, internal standard [12].
3. Results and discussion
Figs. 1 and 2 show, respectively, chromatograms
of hair and retina samples from the animal
identified as No. 6. Table 1 shows the obtained
results. It will be noted that no clenbuterol was
detected, in any of the matrices analysed, in 8 of
the 13 animals.
According to the present results, it is evident
that hair and retina are the most important
matrices in order to determine the highest clenbu-
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terol concentrations. This could be explained
because the pharmacokinetics of clenbuterol in
retina and hair, on one side, and in liver, kidney
and muscle, on the other, were different: liver,
kidney and muscle are very well irrigated blood
tissues in opposition to hair and eye. So, clenbu-
terol accumulates in these later tissues, particu-
larly, if they are pigmented [22,23].
Fig. 1. Chromatogram of a hair sample with clenbuterol.
Fig. 2. Chromatogram of a retina sample with clenbuterol.
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Hair, in fact, is considered as the best matrix to
determine the presence of clenbuterol in living
bovines [15,24/28]. The possibility of an easy,
simple and fast sample collection, with no added
danger for the operator, as is the case with blood
or urine collections, is an advantage which cannot
be disregarded. However, as can be proved by
analysing the results, the hair colour has a major
importance in clenbuterol accumulation [29], par-
ticularly when comparing the rates found in hair
and retina samples of the same animal. The
relation between clenbuterol concentrations found
in hair and retina (hair/retina) can vary between a
minimum of zero, with no perceivable relation, in
the case of a white-haired bovine, and a maximum
of about 4/1, in the case of black-haired bovines,
in-between values of 3/1 being found in brown-
haired animals, or 2/1 when the bovine hair is
blonde.
If the relation of clenbuterol concentrations
noted between hair and retina depends on the
colour of the animal’s hair, the relation between
the concentrations found in the retina and liver
appears to remain relatively constant, at an
approximate value between 6.8 and 12.4
(average/9.569/2.31, n/4).
Clenbuterol concentration in muscle and kid-
ney, where it was possible to determine its
presence, enable that these matrices present the
lowest concentrations found with nearly identical
values, even slightly lower for kidney samples.
Thus, it can be concluded that hair was the best
matrix for clenbuterol control in living bovines,
except when its colour is white, which can be
corroborated through the results obtained with
animal No. 12.
Liver, the alimentary matrix where clenbuterol
remains in greater amounts and for a longer
period, has been responsible for the highest
number of intoxications attributed to the referred
substance [8/12]. Consequently, its analysis is
compulsory whenever there are suspicions of
clenbuterol intoxication.
Eye, or rather retina, is the matrix which gives
the most trustworthy result; having no immediate
alimentary or commercial value, its analysis can be
recommended for all bovines suspected of illegal
fattening. The speed and simplicity of the analysis,
particularly when compared with the other ma-
trices under discussion, is an advantage which
cannot be disregarded, even though there is
inconvenience in providing a very small amount
of sample for analysis*/an average of 1.5/2.5 g
for both eyes together. On the other hand, con-
sidering that the accumulation of clenbuterol in
the retina happens in greater amounts than in any
edible matrix and that the contents in the liver may
be deducted from the value determined in the
retina, it is clear that this matrix must be advised
Table 1
Clenbuterol concentrations in the different matrices (ng/g)
Animal Hair Retina Liver Muscle Kidney Hair colour
1 1655.5 397.8 32.0 3.2 2.7 Black
2 8.6 ND ND ND ND Black
3 ND ND ND ND ND Black
4 ND ND ND ND ND Black
5 ND ND ND ND ND Black
6 123.9 37.3 4.1 1.6 1.5 Brown
7 ND ND ND ND ND Brown
8 ND ND ND ND ND Brown
9 ND ND ND ND ND Brown
10 20.2 8.9 0.9 ND ND Blond
11 ND ND ND ND ND Blond
12 ND 15.0 2.2 ND ND White
13 ND ND ND ND ND White
ND*/not detected.
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as a compulsory reference matrix for any analyses
scheduled for immediately after the slaughter.
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